Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive pulmonary disease (COPD). Aside from the fact that they are ineffective for COPD, these inhalers can pose risks ...

Various types of inhalers, including short- and long-lasting options, are available for managing chronic obstructive pulmonary disease (COPD). A person can get a COPD inhaler through Medicare Part ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... disease (COPD). Sales of Breztri ...

The US Food and Drug Administration's Pulmonary-Allergy Drugs Advisory Committee (PADAC) has voted in favour of GSK and Theravance Inc's chronic obstructive pulmonary disease (COPD) drug.

an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the commencement of a new human subject study for its inhalation therapy program ...

While inhalers are lifesavers for asthma patients ... version of its chronic obstructive pulmonary disease (COPD) inhaler, Breztri. This new propellant, HFO-1234ze, boasts a near-zero global ...